Emmanuel Lacroix
Direktor/Vorstandsmitglied bei Lumos Pharma Sub, Inc.
Ursprung des Netzwerks ersten Grades von Emmanuel Lacroix
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Université Libre de Bruxelles
33
| College/University | Other Consumer Services | 33 |
University of Liege
23
| College/University | Other Consumer Services | 23 |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.
9
| Subsidiary | Investment Managers | 9 |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.
9
| Subsidiary | Medical/Nursing Services | 9 |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.
7
| Holding Company | Medical/Nursing Services | 7 |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom.
3
| Operating Division | Investment Managers | 3 |
EsoBiotec SA
 EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
IMD College
1
| College/University | Other Consumer Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Emmanuel Lacroix
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Analyst | |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Chief Tech/Sci/R&D Officer Masters Business Admin | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Graduate Degree | |
| D'IETEREN GROUP | Other Consumer Services | General Counsel Director/Board Member | |
| EVS BROADCAST EQUIPMENT SA | Electronics/Appliances | Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
I.R.I.S. Group SA
 I.R.I.S. Group SA Computer PeripheralsElectronic Technology I.R.I.S. Group SA provides mobile scanners and document capture solutions. It offers outsourcing, hybrid cloud, enterprise information management, document capture platforms, and consulting services. The company was founded by Pierre de Muelenaere and Jean-Didier Legat in April 1987 and is headquartered in Mont Saint-Guibert, Belgium. | Computer Peripherals | Director of Finance/CFO Chief Executive Officer | |
| MOURY CONSTRUCT SA | Engineering & Construction | Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Graduate Degree | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| New York University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Durham | College/University | Doctorate Degree Undergraduate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Doctorate Degree | |
| University of Utrecht | College/University | Graduate Degree Doctorate Degree | |
Polpharma Biologics Utrecht BV
 Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ghent University | College/University | Graduate Degree Doctorate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ACACIA RESEARCH CORPORATION | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Université Catholique de Louvain | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| Solvay Business School of Economics & Management | College/University | Graduate Degree Graduate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Chairman Director/Board Member | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Founder | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder Chairman |
Statistik
International
| Vereinigte Staaten | 28 |
| Belgien | 13 |
| Vereinigtes Königreich | 4 |
| Niederlande | 4 |
| Irland | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Finance | 5 |
| Industrial Services | 3 |
Operativ
| Director/Board Member | 447 |
| Corporate Officer/Principal | 120 |
| Independent Dir/Board Member | 95 |
| Chairman | 68 |
| Undergraduate Degree | 57 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Ed Mathers Mathers | 47 |
| Daniel Grossmann | 31 |
| Emmett Cunningham | 29 |
| Carole Nüchterlein | 26 |
| Maureen O'Connell | 24 |
| Kevin Lalande | 24 |
| Fiona MacLaughlin | 22 |
| Richard Hawkins | 21 |
| Michel Allé | 20 |
| Cameron Wheeler | 20 |
| Isaac Kohlberg | 20 |
| Peregrine Moncreiffe | 18 |
| Denis Hermesse | 18 |
| Robert A. Heft | 18 |
- Börse
- Insiders
- Emmanuel Lacroix
- Unternehmensverbindungen